Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.

BACKGROUND: When treatment-refractory schizophrenia shows an insufficient response to a trial of clozapine, clinicians commonly add a second antipsychotic, despite the lack of robust evidence to justify this practice. OBJECTIVES: The main objectives of the study were to establish the clinical effect...

全面介紹

Na minha lista:
書目詳細資料
發表在:Health Technol Assess
Main Authors: Barnes, Thomas Re, Leeson, Verity C, Paton, Carol, Marston, Louise, Davies, Linda, Whittaker, William, Osborn, David, Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter M, Husni, Mariwan, Amos, Tim
格式: Artigo
語言:Inglês
出版: NIHR Journals Library 2017
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601255/
https://ncbi.nlm.nih.gov/pubmed/28869006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta21490
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍